The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Is the Treg-engineered donor product Orca-T safe and effective at preventing aGvHD?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the GvHD Hub spoke to Everett H. Meyer, Stanford University, Stanford, US. We asked, Is the Treg-engineered donor product Orca-T safe and effective at preventing acute graft-versus-host disease (GvHD)?

Is the Treg-engineered donor product Orca-T safe and effective at preventing aGvHD?

Meyer talks about the promising results of an ongoing phase II trial evaluating the safety and efficacy of Orca-T in preventing GvHD.

Share: